Russell J. Sanderson

Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery:  Effects of Linker Technology on Efficacy and Toxicity

Svetlana O. Doronina, Brian A. Mendelsohn, Tim D. Bovee et al. · Bioconjugate Chemistry · 2005 · 506 citations

Mab Degradation, Immunology, Immunotherapy +19

Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates

Stephen C. Alley, Dennis R. Benjamin, Scott C. Jeffrey et al. · Bioconjugate Chemistry · 2008 · 456 citations

Immunology, Immunotherapy, Tumor Biology +18

Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate

Nicole M. Okeley, Jamie B. Miyamoto, Xinqun Zhang et al. · Clinical Cancer Research · 2010 · 381 citations · Full text

Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates

May S.K. Sutherland, Russell J. Sanderson, Kristine A. Gordon et al. · Journal of Biological Chemistry · 2006 · 291 citations · Full text

Crystal structure of human uracil-DNA glycosylase in complex with a protein inhibitor: Protein mimicry of DNA

Clifford D. Mol, A.S. Arvai, Russell J. Sanderson et al. · Cell · 1995 · 282 citations · Full text

Crystal Structure, Human Uracil-dna Glycosylase, Protein Inhibitor +7